-
1
-
-
1842612442
-
Androgen receptor outwits prostate cancer drugs
-
DOI 10.1038/nm0104-26
-
Isaacs JT, Isaacs WB,. Androgen receptor outwits prostate cancer drugs. Nat Med 2004; 10 (1): 26-27. (Pubitemid 38524693)
-
(2004)
Nature Medicine
, vol.10
, Issue.1
, pp. 26-27
-
-
Isaacs, J.T.1
Isaacs, W.B.2
-
2
-
-
4744366279
-
Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer
-
DOI 10.1056/NEJMoa040720
-
Tannock IF, de Wit R, Berry WR, Horti J, Pluzanska A, Chi KN, Oudard S, Théodore C, James ND, Turesson I, Rosenthal MA, Eisenberger MA,. Docetaxel plus prednisone or mitoxantrone plus prednisone for advanced prostate cancer. N Engl J Med 2004; 351 (15): 1502-1512. (Pubitemid 39315317)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.15
, pp. 1502-1512
-
-
Tannock, I.F.1
De Wit, R.2
Berry, W.R.3
Horti, J.4
Pluzanska, A.5
Chi, K.N.6
Oudard, S.7
Theodore, C.8
James, N.D.9
Turesson, I.10
Rosenthal, M.A.11
Eisenberger, M.A.12
-
3
-
-
0035496220
-
The development of androgen-independent prostate cancer
-
Feldman BJ, Feldman D,. The development of androgen-independent prostate cancer. Nat Rev Cancer 2001; 1 (1): 34-45. (Pubitemid 33741879)
-
(2001)
Nature Reviews Cancer
, vol.1
, Issue.1
, pp. 34-45
-
-
Feldman, B.J.1
Feldman, D.2
-
4
-
-
4744347762
-
Mechanisms of androgen-refractory prostate cancer
-
DOI 10.1056/NEJMp048178
-
Debes JD, Tindall DJ,. Mechanisms of androgen-refractory prostate cancer. N Engl J Med 2004; 351 (15): 1488-1490. (Pubitemid 39315314)
-
(2004)
New England Journal of Medicine
, vol.351
, Issue.15
, pp. 1488-1490
-
-
Debes, J.D.1
Tindall, D.J.2
-
5
-
-
0029077281
-
Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo
-
Raffo AJ, Perlman H, Chen MW, Day ML, Streitman JS, Buttyan R,. Overexpression of bcl-2 protects prostate cancer cells from apoptosis in vitro and confers resistance to androgen depletion in vivo. Cancer Res 1995; 55 (19): 4438-4445.
-
(1995)
Cancer Res
, vol.55
, Issue.19
, pp. 4438-4445
-
-
Raffo, A.J.1
Perlman, H.2
Chen, M.W.3
Day, M.L.4
Streitman, J.S.5
Buttyan, R.6
-
6
-
-
1542574202
-
Gene Expression Analysis of Human Prostate Carcinoma during Hormonal Therapy Identifies Androgen-Responsive Genes and Mechanisms of Therapy Resistance
-
Holzbeierlein J, Lal P, LaTulippe E, Smith A, Satagopan J, Zhang L, Ryan C, Smith S, Scher H, Scardino P, Reuter V, Gerald WL,. Gene expression analysis of human prostate carcinoma during hormonal therapy identifies androgen-responsive genes and mechanisms of therapy resistance. Am J Pathol 2004; 164 (1): 217-227. (Pubitemid 38364606)
-
(2004)
American Journal of Pathology
, vol.164
, Issue.1
, pp. 217-227
-
-
Holzbeierlein, J.1
Lal, P.2
LaTulippe, E.3
Smith, A.4
Satagopan, J.5
Zhang, L.6
Ryan, C.7
Smith, S.8
Scher, H.9
Scardino, P.10
Reuter, V.11
Gerald, W.L.12
-
7
-
-
33645690200
-
Mechanisms underlying the development of androgen-independent prostate cancer
-
Pienta KJ, Bradley D,. Mechanisms underlying the development of androgen-independent prostate cancer. Clin Cancer Res 2006; 12 (6): 1665-1671.
-
(2006)
Clin Cancer Res
, vol.12
, Issue.6
, pp. 1665-1671
-
-
Pienta, K.J.1
Bradley, D.2
-
8
-
-
34848896887
-
The evolving biology and treatment of prostate cancer
-
DOI 10.1172/JCI31791
-
Taichman RS, Loberg RD, Mehra R, Pienta KJ,. The evolving biology and treatment of prostate cancer. J Clin Invest 2007; 117 (9): 2351-2361. (Pubitemid 47494332)
-
(2007)
Journal of Clinical Investigation
, vol.117
, Issue.9
, pp. 2351-2361
-
-
Taichman, R.S.1
Loberg, R.D.2
Mehra, R.3
Pienta, K.J.4
-
9
-
-
54849435425
-
Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol
-
Dillard PR, Lin MF, Khan SA,. Androgen-independent prostate cancer cells acquire the complete steroidogenic potential of synthesizing testosterone from cholesterol. Mol Cell Endocrinol 2008; 295 (1-2): 115-120.
-
(2008)
Mol Cell Endocrinol
, vol.295
, Issue.12
, pp. 115-120
-
-
Dillard, P.R.1
Lin, M.F.2
Khan, S.A.3
-
10
-
-
70350244512
-
Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens
-
Waltering KK, Helenius MA, Sahu B, Manni V, Linja MJ, Jänne OA, Visakorpi T,. Increased expression of androgen receptor sensitizes prostate cancer cells to low levels of androgens. Cancer Res 2009; 69 (20): 8141-8149.
-
(2009)
Cancer Res
, vol.69
, Issue.20
, pp. 8141-8149
-
-
Waltering, K.K.1
Helenius, M.A.2
Sahu, B.3
Manni, V.4
Linja, M.J.5
Jänne, O.A.6
Visakorpi, T.7
-
11
-
-
67449119425
-
Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven
-
Attard G, Reid AH, Olmos D, de Bono JS,. Antitumor activity with CYP17 blockade indicates that castration-resistant prostate cancer frequently remains hormone driven. Cancer Res 2009; 69 (12): 4937-4940.
-
(2009)
Cancer Res
, vol.69
, Issue.12
, pp. 4937-4940
-
-
Attard, G.1
Reid, A.H.2
Olmos, D.3
De Bono, J.S.4
-
12
-
-
34250221096
-
Characterization of the FAM110 gene family
-
DOI 10.1016/j.ygeno.2007.03.002, PII S0888754307000596
-
Hauge H, Patzke S, Aasheim HC,. Characterization of the FAM110 gene family. Genomics 2007; 90 (1): 14-27. (Pubitemid 46900995)
-
(2007)
Genomics
, vol.90
, Issue.1
, pp. 14-27
-
-
Hauge, H.1
Patzke, S.2
Aasheim, H.-C.3
-
13
-
-
70349766695
-
Evidence for the involvement of FAM110C protein in cell spreading and migration
-
Hauge H, Fjelland KE, Sioud M, Aasheim HC,. Evidence for the involvement of FAM110C protein in cell spreading and migration. Cell Signal 2009; 21 (12): 1866-1873.
-
(2009)
Cell Signal
, vol.21
, Issue.12
, pp. 1866-1873
-
-
Hauge, H.1
Fjelland, K.E.2
Sioud, M.3
Aasheim, H.C.4
-
14
-
-
0019023345
-
Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA
-
Auffray C, Rougeon F,. Purification of mouse immunoglobulin heavy-chain messenger RNAs from total myeloma tumor RNA. Eur J Biochem 1980; 107 (2): 303-314.
-
(1980)
Eur J Biochem
, vol.107
, Issue.2
, pp. 303-314
-
-
Auffray, C.1
Rougeon, F.2
-
15
-
-
0142121516
-
Exploration, normalization, and summaries of high density oligonucleotide array probe level data
-
Irizarry RA, Hobbs B, Collin F, Beazer-Barclay YD, Antonellis KJ, Scherf U, Speed TP,. Exploration, normalization, and summaries of high density oligonucleotide array probe level data. Biostatistic 2003; 4 (2): 249-264.
-
(2003)
Biostatistic
, vol.4
, Issue.2
, pp. 249-264
-
-
Irizarry, R.A.1
Hobbs, B.2
Collin, F.3
Beazer-Barclay, Y.D.4
Antonellis, K.J.5
Scherf, U.6
Speed, T.P.7
-
16
-
-
54349101605
-
Systematic bioinformatic analysis of expression levels of 17330 human genes across 9783 samples from 175 types of healthy and pathological tissues
-
Kilpinen S, Autio R, Ojala K, Iljin K, Bucher E, Sara H, Pisto T, Saarela M, Skotheim RI, Björkman M, Mpindi J-P, Haapa-Paananen S, Vainio P, Edgren H, Wolf M, Astola J, Nees M, Hautaniemi S, Kallioniemi O,. Systematic bioinformatic analysis of expression levels of 17330 human genes across 9783 samples from 175 types of healthy and pathological tissues. Genome Biol 2008; 9 (9): R139.
-
(2008)
Genome Biol
, vol.9
, Issue.9
-
-
Kilpinen, S.1
Autio, R.2
Ojala, K.3
Iljin, K.4
Bucher, E.5
Sara, H.6
Pisto, T.7
Saarela, M.8
Skotheim, R.I.9
Björkman, M.10
Mpindi, J.-P.11
Haapa-Paananen, S.12
Vainio, P.13
Edgren, H.14
Wolf, M.15
Astola, J.16
Nees, M.17
Hautaniemi, S.18
Kallioniemi, O.19
-
17
-
-
28744458859
-
Bioconductor: Open software development for computational biology and bioinformatics
-
Gentleman RC, Carey VJ, Bates DM, Bolstad B, Dettling M, Dudoit S, Ellis B, Gautier L, Ge Y, Gentry J, Hornik K, Hothorn T, Huber W, Iacus S, Irizarry R, Leisch F, Li C, Maechler M, Rossini AJ, Sawitzki G, Smith C, Smyth G, Tierney L, Yang JY, Zhang J,. Bioconductor: Open software development for computational biology and bioinformatics. Genome Biol 2004; 5 (10): R80.
-
(2004)
Genome Biol
, vol.5
, Issue.10
-
-
Gentleman, R.C.1
Carey, V.J.2
Bates, D.M.3
Bolstad, B.4
Dettling, M.5
Dudoit, S.6
Ellis, B.7
Gautier, L.8
Ge, Y.9
Gentry, J.10
Hornik, K.11
Hothorn, T.12
Huber, W.13
Iacus, S.14
Irizarry, R.15
Leisch, F.16
Li, C.17
Maechler, M.18
Rossini, A.J.19
Sawitzki, G.20
Smith, C.21
Smyth, G.22
Tierney, L.23
Yang, J.Y.24
Zhang, J.25
more..
-
18
-
-
4544341015
-
Linear models and empirical bayes methods for assessing differential expression in microarray experiments
-
Article 3
-
Smyth GK,. Linear models and empirical bayes methods for assessing differential expression in microarray experiments. Stat Appl Genet Mol Biol 2004; 3: Article 3.
-
(2004)
Stat Appl Genet Mol Biol
, vol.3
-
-
Smyth, G.K.1
-
19
-
-
0031870740
-
Genetic alterations in hormone-refractory recurrent prostate carcinomas
-
Nupponen NN, Kakkola L, Koivisto P, Visakorpi T,. Genetic alterations in hormone-refractory recurrent prostate carcinomas. Am J Pathol 1998; 153 (1): 141-148. (Pubitemid 28317516)
-
(1998)
American Journal of Pathology
, vol.153
, Issue.1
, pp. 141-148
-
-
Nupponen, N.N.1
Kakkola, L.2
Koivisto, P.3
Visakorpi, T.4
-
20
-
-
74949116742
-
Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer
-
El Gammal AT, Brüchmann M, Zustin J, Isbarn H, Hellwinkel OJ, Köllermann J, Sauter G, Simon R, Wilczak W, Schwarz J, Bokemeyer C, Brümmendorf TH, Izbicki JR, Yekebas E, Fisch M, Huland H, Graefen M, Schlomm T,. Chromosome 8p deletions and 8q gains are associated with tumor progression and poor prognosis in prostate cancer. Clin Cancer Res 2010; 16 (1): 56-64.
-
(2010)
Clin Cancer Res
, vol.16
, Issue.1
, pp. 56-64
-
-
El Gammal, A.T.1
Brüchmann, M.2
Zustin, J.3
Isbarn, H.4
Hellwinkel, O.J.5
Köllermann, J.6
Sauter, G.7
Simon, R.8
Wilczak, W.9
Schwarz, J.10
Bokemeyer, C.11
Brümmendorf, T.H.12
Izbicki, J.R.13
Yekebas, E.14
Fisch, M.15
Huland, H.16
Graefen, M.17
Schlomm, T.18
-
21
-
-
0033551378
-
The role of c-myc in cellular growth control
-
DOI 10.1038/sj.onc.1202751
-
Schmidt EV,. The role of c-myc in cellular growth control. Oncogene 1999; 18 (19): 2988-2996. (Pubitemid 29276538)
-
(1999)
Oncogene
, vol.18
, Issue.19
, pp. 2988-2996
-
-
Schmidt, E.V.1
-
22
-
-
72949116221
-
From pathogenesis to prevention of castration resistant prostate cancer
-
Bonkhoff H, Berges R,. From pathogenesis to prevention of castration resistant prostate cancer. Prostate 2010; 70 (1): 100-112.
-
(2010)
Prostate
, vol.70
, Issue.1
, pp. 100-112
-
-
Bonkhoff, H.1
Berges, R.2
-
23
-
-
0042166174
-
Chromosome aberrations in solid tumors
-
DOI 10.1038/ng1215
-
Albertson DG, Collins C, McCormick F, Gray JW,. Chromosome aberrations in solid tumors. Nat Genet 2003; 34 (4): 369-376. (Pubitemid 36935328)
-
(2003)
Nature Genetics
, vol.34
, Issue.4
, pp. 369-376
-
-
Albertson, D.G.1
Collins, C.2
McCormick, F.3
Gray, J.W.4
-
24
-
-
77449133036
-
Association of HLA class i antigen abnormalities with disease progression and early recurrence in prostate cancer
-
Seliger B, Stoehr R, Handke D, Mueller A, Ferrone S, Wullich B, Tannapfel A, Hofstaedter F, Hartmann A,. Association of HLA class I antigen abnormalities with disease progression and early recurrence in prostate cancer. Cancer Immunol Immunother 2010; 59 (4): 529-540.
-
(2010)
Cancer Immunol Immunother
, vol.59
, Issue.4
, pp. 529-540
-
-
Seliger, B.1
Stoehr, R.2
Handke, D.3
Mueller, A.4
Ferrone, S.5
Wullich, B.6
Tannapfel, A.7
Hofstaedter, F.8
Hartmann, A.9
-
25
-
-
57149087679
-
Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer
-
Wang G, Wang J, Sadar MD,. Crosstalk between the androgen receptor and beta-catenin in castrate-resistant prostate cancer. Cancer Res 2008; 68 (23): 9918-9927.
-
(2008)
Cancer Res
, vol.68
, Issue.23
, pp. 9918-9927
-
-
Wang, G.1
Wang, J.2
Sadar, M.D.3
-
26
-
-
67650758019
-
Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer
-
Wang Q, Li W, Zhang Y, Yuan X, Xu K, Yu J, Chen Z, Beroukhim R, Wang H, Lupien M, Wu T, Regan MM, Meyer CA, Carroll JS, Manrai AK, Jänne OA, Balk SP, Mehra R, Han B, Chinnaiyan AM, Rubin MA, True L, Fiorentino M, Fiore C, Loda M, Kantoff PW, Liu XS, Brown M,. Androgen receptor regulates a distinct transcription program in androgen-independent prostate cancer. Cell 2009; 138 (2): 245-256.
-
(2009)
Cell
, vol.138
, Issue.2
, pp. 245-256
-
-
Wang, Q.1
Li, W.2
Zhang, Y.3
Yuan, X.4
Xu, K.5
Yu, J.6
Chen, Z.7
Beroukhim, R.8
Wang, H.9
Lupien, M.10
Wu, T.11
Regan, M.M.12
Meyer, C.A.13
Carroll, J.S.14
Manrai, A.K.15
Jänne, O.A.16
Balk, S.P.17
Mehra, R.18
Han, B.19
Chinnaiyan, A.M.20
Rubin, M.A.21
True, L.22
Fiorentino, M.23
Fiore, C.24
Loda, M.25
Kantoff, P.W.26
Liu, X.S.27
Brown, M.28
more..
-
28
-
-
0035320526
-
A fresh look at tumor immunosurveillance and immunotherapy
-
DOI 10.1038/86297
-
Smyth MJ, Godfrey DI, Trapani JA,. A fresh look at tumor immunosurveillance and immunotherapy. Nat Immunol 2001; 2 (4): 293-299. (Pubitemid 33706339)
-
(2001)
Nature Immunology
, vol.2
, Issue.4
, pp. 293-299
-
-
Smyth, M.J.1
Godfrey, D.I.2
Trapani, J.A.3
-
29
-
-
0028818052
-
Loss of HLA class i expression in prostate cancer: Implications for immunotherapy
-
Blades RA, Keating PJ, McWilliam LJ, George NJ, Stern PL,. Loss of HLA class I expression in prostate cancer: Implications for immunotherapy. Urology 1995; 46 (5): 681-687.
-
(1995)
Urology
, vol.46
, Issue.5
, pp. 681-687
-
-
Blades, R.A.1
Keating, P.J.2
McWilliam, L.J.3
George, N.J.4
Stern, P.L.5
-
30
-
-
0030834459
-
MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma
-
DOI 10.1002/(SICI)1097-0045(19971201)33:4<233::AID-PROS2>3.0.CO;2-I
-
Bander NH, Yao D, Liu H, Chen YT, Steiner M, Zuccaro W, Moy P,. MHC class I and II expression in prostate carcinoma and modulation by interferon-alpha and -gamma. Prostate 1997; 33 (4): 233-239. (Pubitemid 27524701)
-
(1997)
Prostate
, vol.33
, Issue.4
, pp. 233-239
-
-
Bander, N.H.1
Yao, D.2
Liu, H.3
Chen, Y.-T.4
Steiner, M.5
Zuccaro, W.6
Moy, P.7
-
31
-
-
0034109776
-
Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells
-
Lee HM, Timme TL, Thompson TC,. Resistance to lysis by cytotoxic T cells: A dominant effect in metastatic mouse prostate cancer cells. Cancer Res 2000; 60 (7): 1927-1933. (Pubitemid 30207654)
-
(2000)
Cancer Research
, vol.60
, Issue.7
, pp. 1927-1933
-
-
Lee, H.-M.1
Timme, T.L.2
Thompson, T.C.3
-
32
-
-
3042701410
-
Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class i expression in high-grade prostate cancer
-
Zhang H, Melamed J, Wei P, Cox K, Frankel W, Bahnson RR, Robinson N, Pyka R, Liu Y, Zheng P,. Concordant down-regulation of proto-oncogene PML and major histocompatibility antigen HLA class I expression in high-grade prostate cancer. Cancer Immun 2003; 3: 2.
-
(2003)
Cancer Immun
, vol.3
, pp. 2
-
-
Zhang, H.1
Melamed, J.2
Wei, P.3
Cox, K.4
Frankel, W.5
Bahnson, R.R.6
Robinson, N.7
Pyka, R.8
Liu, Y.9
Zheng, P.10
-
33
-
-
0034622416
-
Changes in beta-2 microglobulin expression in prostate cancer
-
DOI 10.1016/S1078-1439(00)00063-6, PII S1078143900000636
-
Abdul M, Hoosein N,. Changes in beta-2 microglobulin expression in prostate cancer. Urol Oncol 2000; 5 (4): 168-172. (Pubitemid 30408540)
-
(2000)
Urologic Oncology
, vol.5
, Issue.4
, pp. 168-172
-
-
Abdul, M.1
Hoosein, N.2
|